Inventurus Knowledge Solutions Limited Q2 Revenue Rises 104% YoY
Key highlights
- IKS reported Q2 FY27 revenue of ₹1,592.5 crore, up 103.9% year-on-year.
- Q2 FY27 net profit rose 18.1% year-on-year to ₹213.4 crore.
- TruBridge was consolidated for 82 days following its July 9, 2026 acquisition.
- IKS retained its ₹3,000 crore EBITDA target for FY30.
powered by IRIS

Inventurus Knowledge Solutions Limited reported Q2 FY27 revenue of ₹1,592 crore, a 103.9% year-on-year increase, after consolidating 82 days of TruBridge operations; net profit rose 18.1% to ₹213.4 crore. The quarter shows the immediate scale added by the acquisition, while management indicated that TruBridge is in a stabilisation phase for the rest of FY27.
Know Inventurus Knowledge Solutions inside out
Results, valuation, peers and who's buying, in one view.
What did Inventurus Knowledge Solutions Limited report for Q2 FY27?
Inventurus Knowledge Solutions Limited reported revenue from operations of ₹1,592.5 crore for Q2 FY27, compared with the year-earlier period, representing 103.9% growth. Reported EBITDA was ₹441.5 crore, while adjusted EBITDA was ₹459.1 crore. The reported EBITDA margin was about 28%.
IKS reported net profit of ₹213.4 crore, up 18.1% year-on-year. The company filed its Q2 FY27 investor presentation with the exchanges on November 5, 2026, and its earnings call was held on November 6. The reported quarterly results include the financial contribution from the recently acquired TruBridge business.
How did the TruBridge acquisition affect IKS's quarter?
The TruBridge acquisition was the main reason for the sharp increase in reported revenue, as IKS consolidated 82 days of the acquired business during the quarter. Management said TruBridge contributed approximately ₹570 crore in revenue over those 82 days, based on the revenue figure disclosed in the earnings call in US dollars and the reported quarterly consolidation period.
The transaction closed on July 9, 2026. In the conference call, management said the acquired business is being stabilised and integrated, rather than being managed for near-term revenue expansion. TruBridge revenue is expected to remain broadly flat through the rest of FY27, with no significant growth assumed until FY28.
IKS said its approach at TruBridge includes applying its technology-first, human-in-the-loop operating model to the acquired company's revenue-cycle management customer base. Management identified financial health and revenue-cycle management operations as a significant part of the TruBridge book, where it sees scope for changes in global delivery and technology use.
How did the legacy IKS business perform in Q2 FY27?
The legacy IKS business grew a little over 13% year-on-year in constant-currency US dollar terms, according to management. It generated approximately ₹850 crore of revenue in the quarter based on the disclosed US dollar amount, while maintaining an EBITDA margin of about 34.5%.
This performance separates the underlying growth of the original business from the acquisition-led increase in consolidated revenue. The reported 103.9% revenue expansion therefore reflects both organic growth at legacy IKS and the addition of TruBridge for most of the quarter.
The difference in margins is also relevant for investors assessing the consolidated result. IKS reported a consolidated EBITDA margin of about 28%, compared with the approximately 34.5% margin cited for the legacy operation. The company has not provided a separate, fully detailed profitability breakdown for TruBridge in the supplied material.
Got a follow-up? Ask IRIS
What guidance and financial targets did IKS maintain?
IKS reiterated its target of reaching ₹3,000 crore of EBITDA by FY30. Management did not change this longer-term target during the Q2 FY27 call, even as it described FY27 as a consolidation and stabilisation year for the acquired TruBridge operation.
Management also said net leverage, which was below 3 times, could be reduced to close to zero by the end of FY30. This statement presents the company’s stated deleveraging objective following the acquisition, rather than a reported result for the current quarter.
For the near term, the key disclosed operating assumption is that TruBridge revenue will be flat for the rest of FY27. Management’s focus is on integration, operational execution and the application of IKS's delivery and technology model. The company did not provide a significant growth outlook for the acquired business before FY28.
What does the Q2 result mean for investors and operations?
The Q2 result gives investors a first substantial view of the enlarged IKS after TruBridge was consolidated for 82 days. Revenue growth was led primarily by the acquisition, while the legacy business continued to report double-digit constant-currency growth. Net profit growth was materially lower than revenue growth, at 18.1%, making profitability and integration progress important measures alongside revenue.
The earnings call lasted 76 minutes and included 13 questions from eight analysts, indicating investor attention on the acquisition's revenue profile, margins and integration. Management's comments made clear that it does not expect TruBridge to provide meaningful near-term growth during the remainder of FY27.
For customers and operations, the disclosed focus is on stabilising TruBridge and improving its revenue-cycle management processes through global execution and technology intervention. For the broader healthcare-services sector, the transaction adds scale to IKS's reported business, but the supplied disclosures do not include a share-price reaction or an industry-wide financial impact.
Conclusion
IKS delivered Q2 FY27 revenue of ₹1,592.5 crore and net profit of ₹213.4 crore, with 82 days of TruBridge consolidation driving the large increase in reported sales. The legacy business also recorded a little over 13% constant-currency revenue growth, while the lower consolidated EBITDA margin highlights the importance of assessing the acquired operation's integration over time.
The next disclosed milestones are TruBridge stabilisation through the remainder of FY27 and progress toward IKS's FY30 EBITDA target of ₹3,000 crore. Investors will also watch whether the company’s stated plan to reduce net leverage from below 3 times to close to zero by FY30 remains on track as integration continues.


